Physician profile
Krista Barnes
NPI 1073744751
$655.31
in general payments reported to CMS, 2019-2025
14 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.52 · 2023: $387 · 2024: $101 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $143.03 | 2023 | Accufill |
| Kerecis Limited | $83.27 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $74.94 | 2023 | Pico 7 |
| Si-Bone, INC. | $71.37 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $63.49 | 2024 | Eliquis |
| Lilly USA, LLC | $44.09 | 2025 | Kisunla |
| Tactile Systems Technology INC | $37.71 | 2024 | Entre Plus, Flexitouch Plus |
| Pylant Medical | $30.37 | 2025 | |
| Abbott Laboratories | $20.67 | 2025 | Freestyle Libre |
| Exact Sciences Corporation | $18.65 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $18.31 | 2025 | Ozempic |
| Avanir Pharmaceuticals, INC. | $17.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.49 | 2025 | |
| Merck Sharp & Dohme LLC | $14.40 | 2023 | Recarbrio, Zerbaxa, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krista Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.